Business Wire

MAXON Announces Immediate Availability of Cinema 4D Release 19

Jaa

MAXON announces immediate availability of Cinema 4D Release 19 (R19). This next generation of MAXON’s professional 3D application delivers both great tools and enhancements artists can put to use immediately, and provides a peek into the foundations for the future. Designed to serve individual artists as well as large studio environments, Release 19 offers a fast, easy, stable and streamlined workflow to meet today’s challenges in the content creation markets; especially general design, motion graphics, VFX, VR/AR and all types of visualization.

Cinema 4D R19 Feature Highlights Include:

Viewport Improvements – Results so close to final render that client previews can be output using the new native MP4 video support.

MoGraph Enhancements – Added workflow capabilities in Voronoi Fracturing and an all-new Sound Effector.

New Spherical Camera – Lets artists render stereoscopic 360° Virtual Reality videos and dome projections.

New Polygon Reduction Easily reduce entire hierarchies while preserving vertex maps, selection tags and UV coordinates to ensure textures continue to map properly and preserve polygon detail.

Level of Detail (LOD) Object – Define and manage settings to maximize viewport and render speed, or prepare optimized assets for game workflows. Exports FBX for use in popular game engines.

AMD’s Radeon ProRender – Now seamlessly integrated into R19, providing artists with a cross-platform GPU rendering solution.

Revamped Media Core – Completely rewritten software core to increase speed and memory efficiency for image, video and audio formats; native support for MP4 video without QuickTime.

Robust Modeling – A new modeling core with improved support for edges and N-gons can be seen in the Align and Reverse Normals commands.

BodyPaint 3D – Now uses an OpenGL painting engine, giving R19 artists a real-time display of reflections, alpha, bump or normal, and even displacement for improved visual feedback and texture painting when painting color and adding surface details in film, game design and other workflows.

A complete feature list is available at the Release 19 landing page.

European Debut at the IBC 2017 in Amsterdam

MAXON Cinema 4D R19 will make its European debut at the MAXON booth in hall 7, K30 at IBC 2017, which will take place from September 15 – 19, 2017, at the RAI Convention Center in Amsterdam.

In addition, internationally-renowned 3D artists including Peter Eszenyi, Sophia Kyriacou and Tim Clapham as well as other creatives from international studios will share insights into and techniques used on projects created with Cinema 4D. Partners including Google, Insydium, and Redshift will present important workflow integrations with Cinema 4D. Detailed information as well as the live streaming of all presentations will be available at http://www.c4dlive.com/.

Cinema 4D R19 Pricing, Availability and Upgrade Path

Cinema 4D Release 19 is available from MAXON or its authorized dealers. MAXON Service Agreement customers whose MSA is active as of September 1, 2017 will be upgraded automatically. Cinema 4D R19 is available for Mac OS X and Windows; Linux nodes are also available for network rendering. Pricing and distribution information as well as recommended system requirements are available at http://www.maxon.net/.

Imagery and additional information about Cinema 4D R19

Software Screenshots

Pack Shots

Imagery (RGB)

Imagery (CMYK)

New in R19 Website

New in R19 Cineversity Videos

Press Room

About MAXON

Headquartered in Friedrichsdorf, Germany, MAXON Computer is a developer of professional 3D modeling, painting, animation and rendering solutions. Its award-winning Cinema 4D and BodyPaint 3D software products have been used extensively to help create everything from stunning visual effects in top feature films, TV shows and commercials, cutting-edge game cinematics for AAA games, as well for medical illustration, architectural and industrial design applications. MAXON has offices in Germany, USA, United Kingdom, Canada, France, Japan and Singapore. MAXON products are available directly from the web site and its worldwide distribution channel. MAXON is part of the Nemetschek Group.

MAXON Web Resources

Additional information on MAXON can be obtained as follows:

Website

Facebook

Twitter

YouTube

LinkedIn

Google+

Instagram

Contact information

Press Contact
MAXON Computer
US Internal:
press_us@maxon.net
or
US Media Contact:
Vicky Gray-Clark
Ambient Public Relations
408-243-8880
vicky@ambientpr.com
or
UK:
Liam Stacy
press_uk@maxon.net
or
JAPAN:
Toshihide Miyata
press_jp@maxon.net
or
FRANCE:
Eric Godey
press_fr@maxon.net
or
SINGAPORE/ASEAN:
Vincent Ong
press_sg@maxon.net
or
GERMANY and all other countries:
Jessica Wege
press_de@maxon.net

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme